Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local CD research is testing a potential new medication to see if it may reduce recurrent diarrhea, reduced appetite, abdominal pain, frequent fevers, and/or canker sores associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the CD research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for 2–17 years of age to join a Crohn’s disease clinical research study to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or Crohn’s and ulcerative colitis (including associated symptoms such as swollen joints, diarrhea, constant need to poop, malnutrition and/or anemia), consider one of our ICD and UC clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the ICD and UC clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing ulcerative colitis flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce weight loss, unexplained weight loss, bloody stool, chronic fatigue, and/or canker sores associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for young people 2–17 years old to join a clinical research to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderate to severe CD (including associated symptoms such as weight loss, reduced appetite, diarrhea, malnutrition and/or liver disease), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing Crohn’s and UC flare-ups? Local clinical research is testing a potential new medication to see if it may reduce chronic diarrhea, persistent diarrhea, bloody stool, chronic fatigue, and/or liver disease associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for children aged 2 to 17 years to join a CD clinical research to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or Crohn’s and UC (including associated symptoms such as fever, abdominal cramps, diarrhea, chronic fatigue and/or joint pain), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing Crohn’s and UC flare-ups? Local clinical trial is testing a potential new medication to see if it may reduce diarrhea, stomach pain, abdominal pain, chronic fatigue, and/or canker sores associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for children 2 to 17 years old to join a Crohn’s disease clinical trial to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or moderate to severe UC (including associated symptoms such as rectal pain, perianal fistula, bloody stool, malnutrition and/or canker sores), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing moderate to severe UC flare-ups? Local CD research is testing a potential new medication to see if it may reduce abdominal pain or cramping, iron deficiency, bloody stool, malnutrition, and/or liver disease associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the CD research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for 2 to 17 years of age to join a Crohn’s disease (CD) clinical trial to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or ulcerative colitis (including associated symptoms such as diarrhea, abdominal cramps, cramps, frequent fevers and/or anemia), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.